Hyperplasia - 133 Studies Found

Recruiting : Tocilizumab for KSHV-Associated Multicentric Castleman Disease
:
  • Castleman Disease
  • Castleman's Disease : 2011-09-24
    :
    • Drug: Zidovudine Zidovudine (A
Recruiting : TCP Regimen in Newly Diagnosed MCD:a Prospective, Single-center, Single-arm, Phase-II Pilot Trial
: Multicentric Castleman Disease
: 2017-01-31
: Drug: Thalidomide, cyclophosphamide and prednisone

Terminated : Rituximab in the Treatment of HIV Associated Multicentric Castleman Disease Dependent on Chemotherapy
:
  • HIV Infections
  • Giant Lymph Node Hyperplasia

: 2005-08-04
: Drug: Rituximab
Recruiting : Unlock the Cell: Castleman's Disease Flow Cytometry Study
:
  • Castleman Disease
  • Angiofollicular Lymphoi
    : 2016-07-15
    : Procedure: Blood draw/buccal swab The research project will need a blood sample of no more than 50mL per
Recruiting : Castleman Disease Collaborative Network Biobank
:
  • Castleman Disease
  • Castleman's Disease : 2016-08-15
    : Other: Sample Collection Excess blood sample tubes and/or buccal swabs or saliva will have DNA and RNA e
Completed : A Safety and Efficacy Study of CNTO 328 in Patients With B-Cell Non-Hodgkin's Lymphoma, Multiple Myeloma, or Castleman's Disease
:
  • Lymphoma, Non-Hodgkin
  • Multiple Myeloma
  • Castleman Disease
  • Castleman's Disease : 2016-06-22
Withdrawn : Study of Pomalidomide Combined With Modified DA-EPOCH and Rituximab in KSHV-Associated Lymphomas
:
  • Large Cell Lymphoma Arising in KSHV-associated Multicentric Castleman Disease
  • Drug: Pomalidomide Part A: 5 m
Completed : Suramin in Treating Patients With Refractory or Relapsed Multiple Myeloma or Castleman's Disease
: Multiple Myeloma and Plasma Cell Neoplasm
: 1999-11-01
: Drug: suramin
Completed : Dose-escalation Study of Oral CX-4945
:
  • Advanced Solid Tumors
  • Breast Cancer
  • Inflammatory Breast Ca
    : 2009-04-29
    : Drug: CX-4945 oral formulation CX-4945 Capsules, Oral, Dose escalation study, Dose schedule: twice daily
<<< Previous | Next >>>